Disease-A-Month
Volume 54, Issue 8 , Pages 547-564 , August 2008

Allergic Bronchopulmonary Aspergillosis

References 

  1. Zmeili OS, Soubani AO. Pulmonary Aspergillosis: a clinical update. Q J Med. 2007;100:317-4
  2. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis. Thorax. 1952;7:317–333
  3. Pepys J, Riddel RW, Ciron KM, et al. Clinical and immunologic significance of Aspergillus fumigatus in the sputum. Am Rev Respir Dis. 1959;80:167–180
  4. McCarthy DS, Pepys J. Allergic bronchopulmonary aspergillosis: clinical immunolohgy: 1 (Clinical features). Clin Allergy. 1971;1:261–286
  5. Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med. 1991;117:138–142
  6. Greenberger PA, Patterson RJ. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol. 1988;81:646–650
  7. Becker JW, Burke W, McDonald G, et al. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest. 1996;109:1536–1540
  8. Basich JE, Graves TS, Baz MN, et al. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol. 1981;68:98–102
  9. Halwig MJ, Kurup VP, Greenberger PA, et al. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Int Med. 1985;76:55–58
  10. Shah A, Khan ZU, Chaturvedi S, et al. Concomitant allergic aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence of allergic bronchopulmonary aspergillosis. Ann Allergy. 1990;64(6):507–551
  11. Chauhan B, Santiago L, Kirschmann DA, et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol. 1997;159:4072–4076
  12. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2000;106:723–729
  13. Chauhan B, Knutsen AP, Hutcheson PS, et al. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest. 1996;97:2324–2331
  14. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis – state of the art: cystic fibrosis foundation (Consensus conference). Clin Infect Dis. 2003;37(suppl):S225–S2643
  15. Beaumont F, Kauffman HF, de Monchy JGR, et al. Volumetric aerobiological survey of conidal fungi in the North-East Netherlands (II: Comparison of aerobiological data and skin tests with mould extracts in an asthmatic population). Allergy. 1985;40:181–186
  16. Kauffman HF, Tomee JF, van der Werf TS, et al. Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med. 1995;151(6):2109–2115discussion 2116
  17. Gibson PG, Wark PAB, Simpson JL, et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J. 2003;21:582–588
  18. Denning DW, O'Driscoll BR, Hogaboam CM, et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J. 2006;27:615–626
  19. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;110:685–692
  20. Gibson PG. Allergic bronchopulmonary aspergillosis. Semin Respir Crit Care Med. 2006;27(2):185–190
  21. Slavin RG, Hutcheson PS, Chauhan B, et al. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc. 2004;25(6):395–399
  22. Kumar R. Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis (A clinical and serologic evaluation). Chest. 2003;124:890–892
  23. Bahous J, Malo JL, Paquin R, et al. Allergic bronchopulmonary aspergillosis and sensitization to Aspergillus fumigatus in chronic bronchiectasis in adults. Clin Allergy. 1985;15:571–579
  24. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc. 2001;76:930–938
  25. Greenberger PA, Miller TP, Roberts M, et al. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy. 1993;70:333–338
  26. Patterson R, Greenberger PA, Radin RC, et al. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Int Med. 1982;96:286–291
  27. Lee TM, Greenberger PA, Patterson R, et al. Stage V (fibrotic) allergic bronchopulmonary aspergillosis: a review of 17 cases followed from diagnosis. Arch Intern Med. 1987;147:319–323
  28. Geller DE, Kaplowitz H, Light MJ, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Reported prevalence, regional distribution, and patient characteristics. Chest. 1999;116:639–646
  29. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergilosis in cystic fibrosis (Role of atopy and response to itraconazole). Chest. 1999;115:364–370
  30. Skov M, Pressler T, Jensen HE, et al. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax. 1999;54:44–50
  31. Marchant JL, Warner JO, Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis. Thorax. 1994;49:1002–1005
  32. Kraemer R, Delosea N, Ballinari P, et al. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med. 2006;174:1211–1220
  33. Morrissey B, Evans S. Severe bronchiectasis. Clin Rev Allergy Immunol. 2003;25:233–247
  34. Franquet T, Muller NL, Gimenez A, et al. Spectrum of pulmonary aspergillosis: histologic, clinical and radiologic findings. Radiographics. 2001;21:825–837
  35. Al-Alawi A, Ryan CF, Flint JD, et al. Aspergillus-related lung disease. Can Respir J. 2005;12:377–387
  36. Panchal N, Bhagat R, Pant C, et al. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med. 1997;91:213–219
  37. Ward S, Heyneman L, Lee MJ, et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol. 1999;173:937–942
  38. Angus RM, Davies ML, Cowan MD, et al. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to aspergillosus fumigates. Thorax. 1994;49:586–589
  39. Logan PM, Muller NL. High attenuation mucous plugging in allergic bronchopulmonary aspergillosis. Can Assoc Radiol J. 1996;47:374–377
  40. Neeld DA, Goodman LR, Gurney JW, et al. Computed tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis. 1990;142:1200–1205
  41. Webb WR, Müller NL, Naidich DP. High-Resolution CT of the Lung. In: (ed 3). Philadelphia, PA: Lippincott Williams & Wilkins; 2001;p. 505–508
  42. Webb WR. High resolution tomography of obstructive lung disease. Rad Clin North Am. 1994;32:745–757
  43. Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis. Chest. 2007;132:1183–1190
  44. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by aspergillus (Infectious Diseases Society of America). Clin Infect Dis. 2000;30xu(4):696–709
  45. Judson MA, Stevens DA. Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Exp Opin Pharmacother. 2001;2(7):1065–1071
  46. Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in the management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1984;74:68–71
  47. Patterson R, Greenberger PA, Lee TM, et al. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1987;80:663–668
  48. Seaton A, Seaton RA, Wightman AJA. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow up. Q J Med. 1994;87:529–537
  49. Thomson JM, Wesley A, Byrnes CA, et al. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulm. 2006;41:164–170
  50. Salez F, Brichet A, Desurmont S, et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest. 1999;116:1665–1668
  51. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342:756–762
  52. Wark PAB, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003;111:952–957
  53. Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med. 2004;98:915–923
  54. Wark PAB, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev. 2004;3:CD001108
  55. Bolland MJ, Bagg W, Thomas MG, et al. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole. Ann Pharmacother. 2004;38:46–49
  56. Skov M, Main KM, Silleson IB, et al. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budenoside. Eur Respir J. 2002;20:127–133
  57. Hilliard T, Edwards S, Buchdahl R, et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros. 2005;4(4):215–220[Epub 2005 Oct 20]
  58. Van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant ant-IgE antibody. Thorax. 2007;62:276–277

 The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the United States Government.

PII: S0011-5029(08)00057-6

doi: 10.1016/j.disamonth.2008.05.004

Disease-A-Month
Volume 54, Issue 8 , Pages 547-564 , August 2008

Article Tools

* Image Usage & Resolution